P&G/Clarins deal
This article was originally published in The Rose Sheet
Executive Summary
Clarins Fragrance Group will distribute fragrances under the Valentino label in the U.S. under deal with Procter & Gamble, effective immediately, firms announce. Clarins, which distributes P&G's Jean Patou and Lacoste fragrances in specialty stores, department stores and boutiques, maintains it is well suited to distribute the specialty-door Valentino brand. P&G's Prestige Beaute division recently signed a licensing agreement with the Italian designer Valentino to market the brand's fragrances and beauty products (1"The Rose Sheet" Aug. 4, 2003, In Brief)...
You may also be interested in...
Valentino license
Procter & Gamble Prestige Beauté, the beauty division's fine fragrance unit, signed a licensing agreement with Italian fashion designer Valentino to market fragrance and beauty products under the designer name effective Aug. 1, company announces July 30. Valentino license has global growth potential, P&G says, noting agreement is in line with corporate strategy to "develop faster-growing, higher margin, more asset efficient businesses with global leadership potential." Valentino brand has feminine, glamorous heritage that will complement P&G's existing fine fragrance portfolio, firm says. Lineup, which currently includes Hugo Boss, Jean Patou and Lacoste, also will be expanded with addition of Wella fragrance brands. Valentino fragrances previously were marketed by Unilever Prestige...
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.